Analyst Ratings for Amphastar Pharmaceuticals Inc. (AMPH)

Updated: 2017-07-28

Analysts covering Amphastar Pharmaceuticals Inc. (NASDAQ:AMPH) have given it a consensus rating of Buy. Last month, AMPH received an average rating of Buy.

Of the 6 analysts covering the stock, 4 gave it a buy rating, 1 gave an overweight rating, 1 gave a hold rating, 0 issued an underweight rating, and 0 gave a sell rating. Over the past 90 days, the number of analysts that are bullish on the stock has increased by 0. Meanwhile, the number of analysts pessimistic about the company has increased by 0.

Investment analysts gave a few price targets for AMPH. The most optimistic price target was 22, implying potential capital gains of 27.24 percent. The most pessimistic analyst gave a price target of 16, which equates to a potential downside of -7.46 percent. Many analysts are not unbiased in their coverage of stocks, including price targets and stock ratings, so care must be taken in interpreting numbers released by them.

Over the past month, analysts have revised their estimates for this quarter's earnings, with a net average change of 0 percent. The average change in earnings estimates over the last 90 days is -13.39 percent. Meanwhile, fiscal year estimates have been revised upwards by 0 percent, compared to last month. Expanding the time horizon to 3 months, the average change in fiscal year estimates becomes -22.11 percent.

People are often interested in whether analysts were united in the direction of their revisions. 0 analysts have revised their quarterly estimates upwards in the past 30 days, while 0 analysts made negative revisions. During this time, 0 analysts made positive revisions in their estimates for this fiscal year's earnings, while 0 analysts decreased their estimates.

Analysts estimate earnings of AMPH to grow at a rate of 30.84 percent. It's possible to gain additional insight about growth valuation of a company by looking at the PEG ratio. Investors like to see smaller values for the PEG ratio, because that is often interpreted as the company being fairly priced relative to its growth rate. PEG ratios below 1 are often considered desirable, though it could be better to see where the ratio stands relative to peers in the industry. AMPH has a PEG ratio of 2.95.

In the last 52-weeks, AMPH has achieved a high of 21.75 and a low of 12.05. Today's price is 43.49 percent above the 52-week low, and below the high by 20.51 percent. AMPH has a P/E ratio of 91. Investors typically compare the P/E ratio to a company's peers in the industry. The AMPH value stock report compares AMPH to some of its peers using value stock charts. The market cap of AMPH is $0.8059 billion. AMPH will post this quarters earnings in days, on 0000-00-00.